Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Uta Eichmann"'
Publikováno v:
Walther, Sebastian; Mahlberg, Richard; Eichmann, Uta; Kunz, Dieter (2006). Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia. Psychopharmacology, 185(4), pp. 524-8. Berlin: Springer-Verlag 10.1007/s00213-006-0343-1
RATIONALE: Nighttime agitation occurs frequently in patients with dementia and represents the number one burden on caregivers today. Current treatment options are few and limited due to substantial side effects. OBJECTIVES: The aim of the study was t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af7daa5d05bf0e78c68bd9506db87a95
http://doc.rero.ch/record/322101/files/213_2006_Article_343.pdf
http://doc.rero.ch/record/322101/files/213_2006_Article_343.pdf
Autor:
Sören Kuitunen-Paul, Claudia Hägele, Hans-Ulrich Wittchen, Christian Sommer, Quentin J. M. Huys, Daniel J. Schad, Ulrich S. Zimmermann, E Friedel, Michael N. Smolka, Miriam Sebold, Maria Garbusow, Florian Schlagenhauf, Uta Eichmann, Michael A. Rapp, Shuyan Liu, Henrik Walter, Anne Beck, Stephan Nebe, Andreas Heinz, Philipp Sterzer, Nadine Bernhardt
The influence of Pavlovian conditioned stimuli on ongoing behavior may contribute to explaining how alcohol cues stimulate drug seeking and intake. Using a Pavlovian-instrumental transfer task, we investigated the effects of alcohol-related cues on a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::255cfee19186dc64b924447f4930aee6
https://publishup.uni-potsdam.de/frontdoor/index/index/docId/49914
https://publishup.uni-potsdam.de/frontdoor/index/index/docId/49914
Publikováno v:
Archives of Gerontology and Geriatrics. 45:19-26
Acetylcholinesterase inhibitors (AChEIs) are effective in the treatment of cognitive symptoms in Alzheimer's disease (AD). Because the behavioral and psychological symptoms of dementia (BPSD) have also been attributed to central cholinergic deficits,
Autor:
Marcus Ising, Michael Bauer, Mazda Adli, Uta Eichmann, Bruno Müller-Oerlinghausen, Christopher Baethge, Manfred Uhr, Tom Bschor
Publikováno v:
Depression and Anxiety. 17:43-48
Although considerable evidence exists on the efficacy of lithium as an augmenting agent in refractory depression, the underlying neurobiology of this phenomenon is unknown. In patients with major depression, changes of the hypothalamic-pituitary-adre
Autor:
Sieglinde Modell, Heike E. Künzel, Uta Eichmann, Bruno Müller-Oerlinghausen, Michael W. Bauer, Christopher Baethge, Tom Bschor, Mazda Adli, Marcus Ising, Manfred Uhr
Publikováno v:
Neuropsychopharmacology. 27:470-478
Lithium augmentation is a well established strategy for treatment-resistant depression. The exact mode of its action is unknown, but an enhancement of serotonergic transmission is hypothesized. The authors investigated changes in the hypothalamic-pit
Autor:
Heike E. Künzel, Manfred Uhr, Tom Bschor, Mazda Adli, Uta Eichmann, Michael Bauer, Marcus Ising, Christopher Baethge, Bruno Müller-Oerlinghausen, Sieglinde Modell
Publikováno v:
Journal of psychiatric research. 37(2)
Although lithium augmentation is the foremost and most well-documented treatment strategy for treatment resistant depression, knowledge of factors related to response remains scanty. Findings with the combined dexamethasone/corticotropin-releasing ho
Autor:
Tom, Bschor, Christopher, Baethge, Mazda, Adli, Uta, Eichmann, Marcus, Ising, Manfred, Uhr, Bruno, Müller-Oerlinghausen, Michael, Bauer
Publikováno v:
Depression and anxiety. 17(1)
Although considerable evidence exists on the efficacy of lithium as an augmenting agent in refractory depression, the underlying neurobiology of this phenomenon is unknown. In patients with major depression, changes of the hypothalamic-pituitary-adre